DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-672 Cr | ₹-429 Cr | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-672 Cr |
| Mar2025 | ₹-429 Cr |
| Mar2024 | ₹-974 Cr |
| Mar2023 | ₹-629 Cr |
| Mar2022 | ₹-1,276 Cr |
How is Deferred Tax Assets / Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-672 Cr | Negative | |
| Mar2025 | ₹-429 Cr | Negative | |
| Mar2024 | ₹-974 Cr | Negative | |
| Mar2023 | ₹-629 Cr | Negative | |
| Mar2022 | ₹-1,276 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹115,856.1 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
| MANKIND PHARMA | ₹107,613.0 Cr | -1.9% | 14.5% | 15.5% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.8% |
12.6% |
12.3% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses